Benchmark Co. Maintains VolitionRX(VNRX.US) With Hold Rating
VolitionRX (VNRX) Gets a Hold From Benchmark Co.
VolitionRX Analyst Ratings
D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target
VolitionRX Analyst Ratings
VolitionRX Price Target Announced at $5.00/Share by EF Hutton
VolitionRX Analyst Ratings
VolitionRX Analyst Ratings
Benchmark Co. Maintains VolitionRX(VNRX.US) With Hold Rating
VolitionRX Analyst Ratings
EF Hutton Maintains Buy on VolitionRX, Maintains $4 Price Target
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and VolitionRX (VNRX)
VolitionRX Analyst Ratings
VolitionRX (VNRX) Receives a Buy From Cantor Fitzgerald
VolitionRX Analyst Ratings
EF Hutton Maintains Buy on VolitionRX, Maintains $4.5 Price Target
VolitionRX Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Medios AG (OtherMEDOF), Universal Health (UHS) and VolitionRX (VNRX)
EF Hutton Reiterates Buy on VolitionRX, Maintains $4.5 Price Target
VolitionRX Analyst Ratings